Peptides DB
Research-centric peptide and protocol reference hub
Study 15 of 16Eloralintide literatureAmerican journal of medicine open · Observational2026

Clinical Outcomes and Predictors of Adverse Events in Influenza Patients Managed in a Hospital-at-Home Program: A 10-Year Retrospective Study.

Renal impairment and early emergency room visits are important predictors of adverse outcomes in influenza patients managed at home.

Read at American journal of medicine openAdd to compare

Where it sits

this study against the rest of the eloralintide corpus
2
Preclinical
12
Observational · this one
0
Open-label
0
Randomised
2
Reviews

Summary and findings

This study analyzed clinical outcomes in 270 adult patients with laboratory-confirmed influenza managed in a hospital-at-home program over 10 seasons. The study measured emergency room visits, hospital readmissions, and all-cause mortality at 30 and 90 days. Key predictors of adverse outcomes included reduced glomerular filtration rate and early emergency room visits.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
12.4% had ED visits at 30 days, n=270.n=2702026

Abstract

The authors’ words, as American journal of medicine open supplied them

<h4>Background</h4>Hospital-at-home (HaH) is increasingly used to manage acute conditions like influenza, but data on long-term outcomes remain limited.<h4>Objective</h4>To identify clinical predictors of 30- and 90-day adverse outcomes among influenza patients treated at HaH.<h4>Methods</h4>We retrospectively analyzed 270 adult patients with laboratory-confirmed influenza managed at HaH over 10 influenza seasons. Outcomes included emergency room (ER) visits, hospital readmissions, and all-cause mortality at 30 and 90 days.<h4>Results</h4>At 30 days, 12.4% had ED visits, 5.1% were readmitted, and 3.4% died; at 90 days, these increased to 16.2%, 6.5%, and 6.8%, respectively. Multivariable analysis identified reduced glomerular filtration rate (GFR < 60 mL/min/1.73 m²) at discharge and early ER visits as independent predictors of poor outcomes.<h4>Conclusions</h4>Renal impairment and early postdischarge ER use are significant predictors of adverse outcomes in influenza patients managed through HaH. These findings help clinicians optimize risk stratification and follow-up strategies during seasonal influenza peaks.

Background

The study addresses the management of influenza patients in a hospital-at-home setting, which is becoming more common for acute conditions. Previous research has shown limited long-term outcomes for patients treated in this manner. Understanding predictors of adverse outcomes is crucial for optimizing patient care and resource allocation during influenza seasons.

Methods

This was a retrospective analysis of 270 adult patients with laboratory-confirmed influenza treated in a hospital-at-home program over 10 influenza seasons. The primary outcomes measured were emergency room visits, hospital readmissions, and all-cause mortality at 30 and 90 days post-discharge.

Results

At 30 days, 12.4% of patients had emergency department visits, 5.1% were readmitted, and 3.4% died. At 90 days, these figures increased to 16.2% for ED visits, 6.5% for readmissions, and 6.8% for mortality. Multivariable analysis identified reduced glomerular filtration rate (GFR < 60 mL/min/1.73 m²) at discharge and early ER visits as independent predictors of poor outcomes.

Interpretation

The findings suggest that renal impairment and early emergency room visits are significant predictors of adverse outcomes in influenza patients managed at home. While the results are statistically significant, the clinical significance of the effect sizes should be interpreted cautiously. Limitations such as the retrospective nature of the study and potential confounding factors may affect the reliability of the conclusions drawn.

Key findings

  • 12.4% had ED visits at 30 days, n=270.
  • 5.1% were readmitted at 30 days, n=270.
  • 3.4% died at 30 days, n=270.
  • 16.2% had ED visits at 90 days, n=270.
  • 6.5% were readmitted at 90 days, n=270.
  • 6.8% died at 90 days, n=270.

Limitations

  • retrospective analysis may introduce bias
  • potential confounding factors not accounted for
  • single-site study limits generalizability

Elsewhere in the Eloralintide corpus

BHealth service delivery and disease management across Ethiopian health care facilities: An evidence-based analysis of tuberculosis program performance and system determinants.Dialogues in health · 2026 · n=112 · Pediatric TB detection was 2.1% vs. WHO's 12%.reviewBYou are doubly excluded: the interplay of cyberostracism and perceived parental phubbing in predicting problematic smartphone use.Addictive behaviors reports · 2026 · n=428 · Not reported in abstract.HumanBCue-induced inhibitory control in forensic patients with alcohol use disorder: A link to criminal recidivism risk assessed by factor 2 psychopathy.Addictive behaviors reports · 2026 · n=51 · β = -0.79, p = .004HumanBThe Dutch-translated Climate and Health Tool for nurses: cross-cultural adaptation and validation.International journal of nursing studies advances · 2026 · n=292 · Not reported in abstract.reviewBWhen violence meets leadership: Leadership climate as a buffer in the link between violence, harmful alcohol use, and burnout among healthcare workers in Sweden.International journal of nursing studies advances · 2026 · n=2446 · b = 0.007, 95% CI [0.001, 0.016]HumanDEloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial.Lancet (London, England) · 2025